Literature DB >> 4418208

Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human.

M Stafford, G Kellermann, R N Stillwell, M G Horning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4418208

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


× No keyword cloud information.
  4 in total

1.  4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.

Authors:  H Bässmann; J Böttcher; R Schüppel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

2.  Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.

Authors:  A R Boobis; M J Brodie; G C Kahn; E L Toverud; I A Blair; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

3.  Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

4.  Irreversible binding of 3-14C-antipyrine to hepatic protein in vivo and in metabolizing liver microsomes.

Authors:  S Tabarelli-Poplawski; H Uehleke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.